Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Soleno Therapeutics Inc (SLNO)

Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Soleno Therapeutics Secures Up to $200 Million in Loan Agreement with Oxford Finance Quiver Quantitative, Inc. - Wed Dec 18, 1:24AM CST

Soleno Therapeutics secures up to $200 million in financing to support its drug development and anticipated commercial activities.Quiver AI SummarySoleno Therapeutics, Inc. has secured a loan and security...

SLNO : 45.18 (-0.04%)
Soleno Therapeutics Enters Into $200 Million Debt Financing with Oxford Finance LLC GlobeNewswire - Tue Dec 17, 3:05PM CST

SLNO : 45.18 (-0.04%)
Soleno Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference GlobeNewswire - Wed Nov 27, 7:00AM CST

SLNO : 45.18 (-0.04%)
Soleno Therapeutics Announces FDA Extension of NDA Review for DCCR Tablets in Prader-Willi Syndrome Quiver Quantitative, Inc. - Tue Nov 26, 5:52PM CST

FDA extends review of Soleno’s NDA for DCCR tablets treating Prader-Willi syndrome; new decision date is March 27, 2025.Quiver AI SummarySoleno Therapeutics, Inc. announced that the FDA has extended...

SLNO : 45.18 (-0.04%)
Soleno Therapeutics Announces FDA Extension of Review Period for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome GlobeNewswire - Tue Nov 26, 7:30AM CST

SLNO : 45.18 (-0.04%)
Soleno Therapeutics to Present DCCR Clinical Data for Prader-Willi Syndrome at 62nd Annual ESPE Meeting Quiver Quantitative, Inc. - Fri Nov 15, 1:20AM CST

Soleno Therapeutics will present DCCR clinical data for Prader-Willi syndrome at the upcoming ESPE Meeting in Liverpool.Quiver AI SummarySoleno Therapeutics, Inc. announced that it will present data from...

SLNO : 45.18 (-0.04%)
Soleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024 GlobeNewswire - Thu Nov 14, 3:05PM CST

SLNO : 45.18 (-0.04%)
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results GlobeNewswire - Wed Nov 6, 3:05PM CST

SLNO : 45.18 (-0.04%)
Soleno Therapeutics to Participate in Upcoming November Investor Conferences GlobeNewswire - Mon Oct 28, 7:00AM CDT

SLNO : 45.18 (-0.04%)
Soleno Therapeutics Announces the Passing of Former Chairman Ernest Mario, Ph.D. GlobeNewswire - Mon Oct 21, 7:00AM CDT

SLNO : 45.18 (-0.04%)

Barchart Exclusives

How To Profit From The Latest Corporate Spinoffs: A Guide For Investors In 2025 Barchart - Sun Dec 22, 4:00PM CST
How to navigate corporate spinoffs. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot